Stocksigma LogoStocksigma Logo

Nuvama Wealth Management Reports Strong Q2 FY27 Results; Board Approves ₹700 Cr Subsidiary Infusion

Nuvama Wealth Management reported a 26% YoY increase in Q2 FY27 consolidated operating PAT to ₹319 Cr (reported PAT up 19% YoY to ₹304 Cr), driven by 21%

Nuvama Wealth Management Reports Strong Q2 FY27 Results; Board Approves ₹700 Cr Subsidiary Infusion

Nuvama Wealth Management Ltd · Outcome · 06 Nov 2026, 7:33 pm

Nuvama Wealth Management Reports Strong Q2 FY27 Results; Board Approves ₹700 Cr Subsidiary Infusion Nuvama Wealth Management reported a 26% YoY increase in Q2 FY27 consolidated operating PAT to ₹319 Cr (reported PAT up 19% YoY to ₹304 Cr), driven by 21% YoY revenue growth to ₹937 Cr. H1 FY27 operating PAT rose 21% YoY to ₹625 Cr, with RoE at ~29% and client assets expanding 25% YoY to ₹5.5 trillion. On 6th Nov'26, the board also approved equity investments of up to ₹400 Cr in Nuvama Wealth Finance and ₹300 Cr in Nuvama Wealth and Investment.

Original exchange filing (PDF)

More announcements from Nuvama Wealth Management Ltd

All Nuvama Wealth Management Ltd announcements